Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study

Aydin, Yavuz; Atis, Alev; Kaleli, SEMİH; Uludag, Seyfettin; Goker, Nimet

doi:10.1016/j.ejogrb.2010.02.024

Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: a randomised, open-label study

Aydin Y., Atis A., Kaleli S., Uludag S., Goker N.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.150, sa.2, ss.203-206, 2010 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 150 Sayı: 2
Basım Tarihi: 2010
Doi Numarası: 10.1016/j.ejogrb.2010.02.024
Dergi Adı: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.203-206
Anahtar Kelimeler: Mastalgia, Premenstrual syndrome, Prolactin, Breast, Pain, CYCLICAL MASTALGIA, PARKINSONS-DISEASE, DOPAMINE AGONISTS, MANAGEMENT, TOREMIFENE, TAMOXIFEN, METAANALYSIS, MULTICENTER, TRIAL, WOMEN
İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objective: To compare the effectiveness and side effects of cabergoline with bromocriptine for the symptomatic treatment of cyclic mastalgia as a part of the premenstrual syndrome.